In a UK first, researchers in Manchester are successfully identifying patients in the early, curable stages of a common liver ...

Direct-acting antivirals (DAAs) have dramatically changed the landscape of chronic hepatitis C virus (HCV) treatment and significantly reduced the risk of HCV-related hepatocellular carcinoma (HCC) ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

Hepatitis C virus (HCV) infection remains a major global health burden, affecting millions worldwide and contributing significantly to hepatocellular ...

In a UK first, researchers in Manchester are successfully identifying patients in the early, curable stages of a common liver ...

Tvaster Genkalp secured $1.25 million in pre-series A funding led by Ideaspring Capital to expand Episcreen Liver, a ...

[97] Complete necrosis was obtained in 69% of HCC 2 cm or smaller ... portal vein invasion and AFP level, with a hazard ratio (HR) of each ranging from 1.48 to 2.52. A meta-analysis of 18 RCTs ...

were more likely to develop HCC at a younger age than patients with hepatitis C (HCV) (HBV-26% under age 40, HCV-0% under age 40; p < 0.001), with greater serum alpha-Fetoprotein production ...